United Kingdom· GB-APID-20558911000001100
Eviplera 200mg/25mg/245mg tablets
A emtricitabine, tenofovir disoproxil and rilpivirine product containing emtricitabine + rilpivirine + tenofovir disoproxil, registered in United Kingdom by Gilead Sciences Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir disoproxil and rilpivirine is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR08 (emtricitabine, tenofovir disoproxil and rilpivirine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir disoproxil and rilpivirine · ATC J05AR08
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Emtricitabine + Rilpivirine + Tenofovir disoproxil
- Manufacturer
- Gilead Sciences Ltd
- Country
- United Kingdom (GB)
- ATC code
- J05AR08
- ATC class
- Emtricitabine, tenofovir disoproxil and rilpivirine
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5391507140432
- gtin05391507145147
- gtin05391507145154
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir disoproxil and rilpivirine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandEvipleraGilead Sciences Ireland UC
- United StatesCOMPLERAGilead Sciences, Inc.
- NorwayEviplera2care4 ApS
- CzechiaEVIPLERAGilead Sciences Ireland UC, Carrigtohill
- IcelandEvipleraGilead Sciences Ireland UC*
- PolandEvipleraGilead Sciences Ireland UC
- SwedenEviplera 200 mg/25 mg/245 mg Filmdragerad tablettGilead Sciences Ireland UC
- IrelandEviplera 200 mg/25 mg/245 mg film-coated tabletsGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Eviplera
- Liechtenstein · Eviplera
- Norway · Eviplera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2c8cc455-18a5-4ebf-8e62-23f030d48b36 GET /v1/drugs/2c8cc455-18a5-4ebf-8e62-23f030d48b36?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "20558911000001100",
"desc": "Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd)",
"form": "Oral tablet",
"vpid": "20594611000001108",
"source": "dmd",
"vtm_id": "21203311000001100",
"strength": "200 mg",
"substance": "Emtricitabine + Rilpivirine + Tenofovir disoproxil",
"ingredient": "Emtricitabine",
"supplier_code": "2572301000001107"
}See everything about emtricitabine, tenofovir disoproxil and rilpivirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.